NCT07447635 Testing an MBI for Smoking Cessation and Alcohol Use Among Cancer Survivors
| NCT ID | NCT07447635 |
| Status | Recruiting |
| Phase | — |
| Sponsor | H. Lee Moffitt Cancer Center and Research Institute |
| Condition | Smoking Cessation |
| Study Type | INTERVENTIONAL |
| Enrollment | 600 participants |
| Start Date | 2026-05-15 |
| Primary Completion | 2029-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 600 participants in total. It began in 2026-05-15 with a primary completion date of 2029-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will examine the efficacy of Mindfulness-Based Relapse Prevention for Smoking and Alcohol (MBRP-SA) compared to standard care among cancer survivors who smoke cigarettes and engage in at-risk alcohol use. Investigators will evaluate implementation outcomes through structured stakeholder interviews across medical centers, cancer-focused organizations, and community-based programs in Florida, and will conduct a cost-assessment and an incremental cost-effectiveness analysis of the two conditions.
Eligibility Criteria
Inclusion Criteria: * ≥18 years old * History of a cancer diagnosis at any point in lifetime * Smoked ≥1 cigarette/day in past month * At least one binge drinking episode in past month or exceeds weekly drinking limits * Motivated to quit smoking and modify alcohol use in next 30 days * Valid home address in Florida * English-speaking, reading, and writing ability Exclusion Criteria: * Pregnancy or lactation * Active psychotic disorder * History of severe alcohol withdrawal * Current use of tobacco cessation medication or other treatments to quit smoking * End-of-life or hospice care * Household member already enrolled
Contact & Investigator
Christine Vinci, PhD
PRINCIPAL INVESTIGATOR
Moffitt Cancer Center
Frequently Asked Questions
Who can join the NCT07447635 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Smoking Cessation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07447635 currently recruiting?
Yes, NCT07447635 is actively recruiting participants. Contact the research team at Skye.Dougan@moffitt.org for enrollment information.
Where is the NCT07447635 trial being conducted?
This trial is being conducted at Tampa, United States.
Who is sponsoring the NCT07447635 clinical trial?
NCT07447635 is sponsored by H. Lee Moffitt Cancer Center and Research Institute. The principal investigator is Christine Vinci, PhD at Moffitt Cancer Center. The trial plans to enroll 600 participants.